After hours: 4:22PM EDT
|Bid||132.57 x 1100|
|Ask||132.52 x 1100|
|Day's Range||132.05 - 135.52|
|52 Week Range||101.42 - 142.50|
|Beta (3Y Monthly)||0.95|
|PE Ratio (TTM)||32.12|
|Earnings Date||Jul 24, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||148.57|
PALO ALTO, Calif. , June 26, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its third quarter fiscal year 2019 earnings release date. The Company will report results for the third quarter of fiscal ...
Collaboration with Tennessee Oncology Aims to Improve Access to Care Across Rural Patient Populations PALO ALTO, Calif. , June 26, 2019 /PRNewswire/ -- Providing cancer patients an opportunity for increased ...
PALO ALTO, Calif. , June 17, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its acquisition of Cancer Treatment Services International (CTSI). There were no changes ...
PALO ALTO, Calif. , June 13, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be delivering presentations focused on artificial intelligence (AI), federated data sources and clinical decision ...
MÜNSTER, Germany, June 12, 2019 /PRNewswire/ -- Varian (VAR) will showcase and discuss its latest innovations in radiotherapy at the DEGRO 25 (German Society for Radio Oncology) meeting in Münster, Germany, June 13-16. At the core of the company's DEGRO 25 meeting activities is its Halcyon™ radiotherapy system, which has gone live at seven treatment centers in Germany. During a lunch symposium on June 14 (time and location: see below), Dr. Johannes Gollrad from Charité Universitätsmedizin Berlin as well as Prof. Dr. Florian Würschmidt and Dr. Matthias Kretschmer from Radiologische Allianz Hamburg will discuss their experience with Halcyon.
PALO ALTO, Calif. , June 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced it will be showcasing its Bravos ™ afterloader system for High Dose Rate (HDR) brachytherapy treatments and other advanced ...
PALO ALTO, Calif., June 10, 2019 /PRNewswire/ -- Varian (VAR) today announced it has acquired Austin, Texas-based Endocare and Hangzhou, China-based, Alicon, to expand its portfolio of multidisciplinary integrated cancer care solutions.
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity. As a result, most investors pick their illusory “winners” by making a superficial analysis and research that leads to poor performance on aggregate. Since stock returns aren't usually symmetrically distributed and index […]
Varian Medical Systems Inc NYSE:VARView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for VAR with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting VAR. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding VAR totaled $4.98 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
PALO ALTO, Calif. and HERLEV, Denmark, June 10, 2019 /PRNewswire/ -- Varian (VAR) today announced Herlev University Hospital near Copenhagen, Denmark is Scandinavia's first facility to utilize the Halcyon™ system. The first patient treated on the system was a 42-year-old female undergoing treatment for anal cancer.
PALO ALTO, Calif. , June 7, 2019 /PRNewswire/ -- Providing access to proton therapy treatment for cancer patients in the tri-state area, the New York Proton Center (NYPC) held a ribbon cutting event yesterday ...
PALO ALTO, Calif. , June 7, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be hosting its second FlashForward ™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58 th annual Particle ...
PALO ALTO, Calif. , June 6, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced it will be showcasing its new ProBeam ® 360° proton therapy system*, June 12 th -15 th in Manchester, United Kingdom at the ...
With a market capitalization of US$12b, Varian Medical Systems, Inc. (NYSE:VAR) is a large-cap stock, which is...
PALO ALTO, Calif. , May 29, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing its Noona ® patient management system and its 360 Oncology™ care management platform, May 31-June ...
PALO ALTO, Calif. , May 28, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced a physicist using Varian's Eclipse ™ treatment planning system achieved the top overall score in the TROG 2019 Stereotactic ...
Here's a look at some of the deals and dollars involving North Texas companies and firms this week.
Varian (VAR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.